Association between serum magnesium levels and cognitive function in patients undergoing hemodialysis
Related Experiment Video
Updated: Jun 22, 2025

Measurement of Tissue Oxygenation Using Near-Infrared Spectroscopy in Patients Undergoing Hemodialysis
Published on: October 2, 2020
Kazuhiko Kato1,2, Akio Nakashima3, Shunichiro Shinagawa4
1Division of Nephrology and Hypertension, Department of Internal Medicine, The Jikei University School of Medicine, Tokyo, Japan.
Insights
Higher serum magnesium levels correlate with better cognitive function in hemodialysis patients. Other CKD-MBD markers like PTH and vitamin D showed no significant association with cognition.
Area of Science:
- Nephrology
- Neurology
- Biochemistry
Background:
- The link between chronic kidney disease-mineral and bone disorder (CKD-MBD) and cognitive impairment is not well understood.
- CKD-MBD is common in patients undergoing hemodialysis.
Purpose of the Study:
- To investigate the association between CKD-MBD markers and cognitive function in hemodialysis patients.
- To explore the role of serum magnesium, PTH, 25-OHD, FGF-23, and α-klotho in cognitive health.
Main Methods:
- Cross-sectional study of 390 hemodialysis patients aged 65 years or older without diagnosed dementia.
- Cognitive function assessed using Montreal Cognitive Assessment (MoCA) and Mini-Mental State Examination (MMSE).
- Serum levels of magnesium, intact PTH, 25-OHD, FGF-23, and soluble α-klotho were measured.
Main Results:
- Patients with higher serum magnesium levels demonstrated significantly better MoCA and MMSE scores.
- Unadjusted and adjusted analyses confirmed a positive association between high magnesium and preserved cognitive function.
- No significant associations were found between cognitive function and intact PTH, 25-OHD, FGF-23, or soluble α-klotho.
Conclusions:
- Elevated serum magnesium levels may be linked to preserved cognitive function in hemodialysis patients.
- Serum magnesium is a potential factor influencing cognitive health in this population.
- Other CKD-MBD markers studied do not appear to have a direct association with cognitive function.
Background:
The relationship between chronic kidney disease-mineral and bone disorder (CKD-MBD) and cognitive function remains largely unknown. This cross-sectional study aimed to explore the association between CKD-MBD and cognitive function in patients on hemodialysis.
Methods:
Hemodialysis patients aged ≥ 65 years without diagnosed dementia were included. Cognitive function was assessed using the Montreal Cognitive Assessment (MoCA) and Mini-Mental State Examination (MMSE). CKD-MBD markers, serum magnesium, intact parathyroid hormone (PTH), 25-hydroxyvitamin D (25-OHD), fibroblast growth factor (FGF)-23, and soluble α-klotho were measured.
Results:
Overall, 390 patients with a median age of 74 (interquartile range, 70-80) years, mean serum magnesium level of 2.4 ± 0.3 mg/dL, and median MoCA and MMSE scores of 25 (22-26) and 28 (26-29), respectively, were analyzed. MoCA and MMSE scores were significantly higher (preserved cognitive function) in the high-magnesium group than in the low-magnesium group according to the unadjusted linear regression analysis (β coefficient [95% confidence interval (CI)] 1.05 [0.19, 1.92], P = 0.017 for MoCA; 1.2 [0.46, 1.94], P = 0.002 for MMSE) and adjusted multivariate analysis with risk factors for dementia (β coefficient [95% CI] 1.12 [0.22, 2.02], P = 0.015 for MoCA; 0.92 [0.19, 1.65], P = 0.014 for MMSE).
Conclusions:
Higher serum magnesium levels might be associated with preserved cognitive function in hemodialysis patients. Conversely, significant associations were not observed between cognitive function and intact PTH, 25-OHD, FGF-23, or soluble α-klotho levels.
Related Concept Videos
Dialysis
Acute kidney injury develops suddenly and can be caused by pre-renal causes (e.g., hypovolemia, shock), intrinsic renal causes (e.g., acute tubular necrosis), or post-renal causes (e.g., urinary obstruction). In contrast, chronic renal failure progresses gradually over time and is often...
Factors Affecting Renal Clearance: Renal Impairment
One condition associated with renal failure is uremia. Uremia is characterized by impaired glomerular filtration and fluid accumulation in the body. This condition hinders the renal clearance of drugs, resulting in drug accumulation and potential...
Antihypertensive Drugs: Potassium-Sparing Diuretics
Cognitive Enhancers: Cholinesterase Inhibitors and NMDA Receptor Antagonists
Heart Failure Drugs: Diuretics

